Showing results (171-180 of 237) with videos related to
Sort By:
Pageof 24
Journal of Neurosurgery|August 15, 2015
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomesAriel E Marciscano, Anat O Stemmer-Rachamimov, Andrzej Niemierko, et al.Neuro-Oncology|November 10, 2011
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cellsHiroaki Wakimoto, Gayatry Mohapatra, Ryuichi Kanai, et al.Journal of Surgical Education|August 5, 2026
Implementation of an Intern Night Float Rotation in a Neurosurgery Residency Program: Perspectives on Patient Safety and Educational ValueGrace Y Ng, Mercy H Mazurek, Kelly Cruise, et al.Journal of Neuro-Oncology|July 24, 2012
Prospective, high-throughput molecular profiling of human gliomasAndrew S Chi, Tracy T Batchelor, Dora Dias-Santagata, et al.Cancer Immunology, Immunotherapy : CII|October 9, 2025
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxMHenry G Withers, Sheila A Figel, Jingxin Qiu, et al.Cerebral Cortex (New York, N.Y. : 1991)|October 9, 2023
Cases of familial idiopathic normal pressure hydrocephalus implicate genetic factors in disease pathogenesisAna B W Greenberg, Neel H Mehta, Kedous Y Mekbib, et al.World Neurosurgery|October 2, 2019
Navigable Channel-Based Trans-Sulcal Resection of Third Ventricular Colloid Cysts: A Multicenter Retrospective Case Series and Review of the LiteratureMichelle Lin, Joshua Bakhsheshian, Ben Strickland, et al.Neuro-Oncology|November 25, 2015
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological gradeWilliam L Hwang, Ariel E Marciscano, Andrzej Niemierko, et al.Neuro-Oncology|June 7, 2022
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experienceAnurag Saraf, Torunn I Yock, Andrzej Niemierko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.Pageof 24